US IPO Recap: Textura and LightInTheBox gain over 30%, eight companies file


Three companies priced US IPOs last week, while the fourth (and largest) expected deal, Colony American Homes (CAHS), was postponed. Two of the priced deals, Textura ( TXTR ) and LightInTheBox ( LITB ), gained more than 30%, but the third, RCS Capital ( RCAP ), ended the week 3% below its offer price. Two biotechs launched deals, and eight companies, half of which plan to raise more than $300 million, made initial IPO filings .

IPO pricings (week of June 3, 2013)
Company (Ticker) Business Deal Size ($mm) Price vs. Midpoint Return
LightInTheBox ( LITB ) Chinese online retailer $79 0% 32%
RCS Capital ( RCAP ) Broker-dealer for REITs $50 0% -3%
Textura ( TXTR ) Construction project software $75 7% 39%

LightInTheBox is first Chinese company to list in the US since YY

LightInTheBox, which sells China-made products to consumers in Europe and the US, was the first IPO from a Chinese company in 2013, despite the tremendous success of the two US IPOs from China in 2012, Vipshop ( VIPS ) and YY ( YY ). Vipshop, another e-commerce company, is the best performing IPO since November 2011, having quadrupled in price; YY, a social platform, is up 174%. Textura had the latest strong debut from a software company, rising 39% on its first day of trading on Friday. It has sold to 41 of the top 100 contractors in North America, and its sales are growing at 50%+. Colony American Homes was the first company since mid-April to postpone an IPO.

IPOs setting terms (week of June 3, 2013)
Company (Ticker) Business Deal Size ($mm) LTM Sales ($mm)
bluebird bio (BLUE) Early-stage biotech $75 $1
China Commercial Credit (CCCR) Microcredit in China $18 $12
PTC Therapeutics (PTCT) Late-stage biotech $100 $29

With biotechs attracting big returns, two more launch deals

Following Epizyme's 53% first-day gain in the prior week (it is now up 73%), bluebird bio (BLUE) and PTC Therapeutics (PTCT), both development-stage biotechs, set terms. PTC Therapeutics first filed for an IPO in 2006 but withdrew in 2007. It has a drug candidate for muscular dystrophy and cystic fibrosis in Phase 3 trials. Backed by Third Rock Ventures, bluebird bio is developing therapies for genetic and orphan diseases.

New IPO filers (week of June 3, 2013)
Company (Ticker) Business Deal Size ($mm) LTM Sales ($mm)
American Homes 4 Rent (AMH) Residential REIT $1,250 $11
Athlon Energy (ATHL) Oil and gas E&P $345 $179
Cellular Dynamics International (ICEL) Cell manufacturing $57 $8
China Commercial Credit (CCCR) Microcredit in China $18 $12
Volaris Aviation (VLRS) Mexican airline $100 $1,011
Graña y Montero (GRAM) Engineering/construction $460 $2,086
NRG Yield (NYLD) Energy assets $400 $184
Tecogen (TGEN) Utility systems $25 $16

Three foreign deals among eight added to the pipeline

For the second consecutive week, two foreign companies with more than $1 billion in sales filed for US IPOs. Graña y Montero is Peru's largest engineering and construction company, and Volaris Aviation is a low-cost airline based in Mexico. The day before Colony American Homes postponed its deal, another REIT that leases single-family properties, American Homes 4 Rent, filed for a $1.3 billion IPO. Backed by Apollo, Athlon Energy (ATHL) is the second E&P to file this year, after Jones Energy (JONE) filed in the prior week.

IPO market snapshot
The 77 IPOs in 2013 have raised $17.2 billion and produced an average return of 19%. There have been 55 IPOs in the past 90 days, with total proceeds of $11.3 billion and an average return of 19%. The active IPO pipeline includes 111 companies looking to raise $32.6 billion.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ, Inc.

This article appears in: News Headlines , IPOs

Referenced Stocks: LITB , RCAP , TXTR , VIPS , YY

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos



Most Active by Volume

  • $15.38 ▼ 1.09%
  • $110.38 ▲ 0.73%
  • $104.01 ▲ 1.75%
  • $6.3801 ▼ 53.60%
  • $4.25 ▲ 4.94%
  • $15.91 ▲ 7.72%
  • $4.64 ▲ 11.27%
  • $25.47 ▲ 1.11%
As of 10/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by